291 related articles for article (PubMed ID: 34733371)
1. lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis.
Guo H; Lin S; Gan Z; Xie J; Zhou J; Hu M
Oncol Lett; 2021 Dec; 22(6):853. PubMed ID: 34733371
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FOXD3-AS1/miR-135a-5p function in nasopharyngeal carcinoma cells.
E Z; Li C; Xiang Y
Open Med (Wars); 2020; 15(1):1193-1201. PubMed ID: 33336076
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p.
Wu Q; Shi M; Meng W; Wang Y; Hui P; Ma J
J Cell Physiol; 2019 Dec; 234(12):21889-21902. PubMed ID: 31058315
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
[TBL] [Abstract][Full Text] [Related]
6. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
[TBL] [Abstract][Full Text] [Related]
7. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
[TBL] [Abstract][Full Text] [Related]
9. Silencing of OIP5-AS1 Protects Endothelial Cells From ox-LDL-Triggered Injury by Regulating KLF5 Expression via Sponging miR-135a-5p.
Zhao M; Yang Y; Li J; Lu M; Wu Y
Front Cardiovasc Med; 2021; 8():596506. PubMed ID: 33778018
[No Abstract] [Full Text] [Related]
10. FOXD3-AS1 Knockdown Suppresses Hypoxia-Induced Cardiomyocyte Injury by Increasing Cell Survival and Inhibiting Apoptosis
Zheng J; Peng B; Zhang Y; Ai F; Hu X
Front Pharmacol; 2020; 11():1284. PubMed ID: 32973515
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
Wu C; Lin W; Fu F
Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
[TBL] [Abstract][Full Text] [Related]
12. FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis.
Ji T; Zhang Y; Wang Z; Hou Z; Gao X; Zhang X
Cancer Biomark; 2020; 29(3):417-427. PubMed ID: 32924985
[TBL] [Abstract][Full Text] [Related]
13. SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p/HMGA1 pathway.
Ma WG; Shi SM; Chen L; Lou G; Feng XL
J Cell Biochem; 2021 Feb; 122(2):235-248. PubMed ID: 32959937
[TBL] [Abstract][Full Text] [Related]
14.
Wan N; Yang W; Cheng H; Wang J
Cancer Biother Radiopharm; 2020 Oct; 35(8):596-604. PubMed ID: 32354225
[No Abstract] [Full Text] [Related]
15. LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis.
Zeng Z; Zhao G; Zhu H; Nie L; He L; Liu J; Li R; Xiao S; Hua G
Cancer Cell Int; 2020; 20():350. PubMed ID: 32742197
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA C5orf66-AS1 inhibits osteosarcoma cell proliferation and invasion via miR-149-5p upregulation.
Zhang H; Song J
Oncol Lett; 2021 Nov; 22(5):757. PubMed ID: 34539861
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of lncRNA NUTM2A-AS1 inhibits lung adenocarcinoma cell viability by regulating the miR-590-5p/METTL3 axis.
Wang J; Zha J; Wang X
Oncol Lett; 2021 Nov; 22(5):798. PubMed ID: 34630705
[TBL] [Abstract][Full Text] [Related]
18. LncRNA FOXD3-AS1 promotes proliferation, invasion and migration of cutaneous malignant melanoma via regulating miR-325/MAP3K2.
Chen X; Gao J; Yu Y; Zhao Z; Pan Y
Biomed Pharmacother; 2019 Dec; 120():109438. PubMed ID: 31541886
[TBL] [Abstract][Full Text] [Related]
19. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA SLC25A25-AS1 exhibits oncogenic roles in non-small cell lung cancer by regulating the microRNA-195-5p/ITGA2 axis.
Chen J; Gao C; Zhu W
Oncol Lett; 2021 Jul; 22(1):529. PubMed ID: 34055094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]